logo-loader
ASX:ZLD OTCQB:ZLDAF

Zelira Therapeutics Ltd

 Receive alerts
Market:
ASX
Market Cap:
$59.91 m
Price
0.06 AUD
Change
-7.46%
52 weeks high
0.09
52 weeks low
0.02
01.24

Director Interviews

In brief

Zelira Therapeutics Ltd (ASX:ZLD) is a medicinal cannabis company focused on first-in-class human clinical trials for insomnia, autism and opioid reduction

In brief Deep dive Research Latest news Insight Interviews

Deep dive We explore the investor case for growth companies

Zelira Therapeutics accelerates towards commercialisation in 2020
Zelira Therapeutics Ltd - Zelira Therapeutics accelerates towards commercialisation in 2020

Snapshot

The global therapeutic medicinal cannabis company owns a portfolio of proprietary products positioned to enter global markets from 2020.

Open Deep dive

Latest news

Zelira Therapeutics finalises appointment terms of US CEO and managing director

3 days, 3 hours ago

Zelira Therapeutics signs commercial agreement for supply of Insomnia and...

1 week, 5 days ago

Pharma companies buck the trend to outshine other sectors in Asia-Pacific region

on 8/5/20

Emerald Clinics on track with investments towards RWE data platform

on 1/5/20

Zelira Therapeutics in discussions to license medicinal cannabis products in US

on 30/4/20

Zelira Therapeutics shares surge after clinically validating medicinal...

on 7/4/20

Emerald Clinics sees potential in filling evidence gap for cannabinoid products

on 5/3/20

Emerald Clinics gets nod for Zelira's opioid sparing clinical trial

on 27/2/20

Interviews

Zelira Therapeutics Ltd - Zelira Therapeutics releases interim data for Phase II clinical trial for insomnia Health Full interview: Zelira Therapeutics releases interim data for Phase II clinical trial for insomnia
on 21/2/20
Zelira Therapeutics Ltd - Zelira Therapeutics on its acquisition with Ilera Health Full interview: Zelira Therapeutics on recent acquisition with Ilera
on 2/12/19
1552365914_zld-mar.jpg Health Ilera Healthcare deal is 'one piece of the puzzle' for Zelda Therapeutics in 'globalising product'
on 12/3/19
1543557103_ZLD-DR.JPG Health Zelda Therapeutics poised to 'value add all the way from clinical trials to the market'
on 3/12/18
View all